The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: IG Design plunges after profit warning

Wed, 26th Jan 2022 11:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Sensyne Health PLC, up 25% at 19.00 pence, 12-month range 14.00p-190.00p. The healthcare technology firm says it has successfully completed a financing agreement for up to GBP11.4 million. Earlier this month, Sensyne had warned it would not be able to trade beyond February without the cash injection.

----------

Revolution Beauty Group PLC, up 14% at 110.00p, 12-month range 95.18p-173.00p. The beauty and personal care products maker and retailer reports strong sales over the peak Christmas trading period, which increased 41% year-on-year on an underlying basis. Says this was achieved despite a volatile consumer backdrop with many markets going into lockdown. Expands into US with product rollout into over 2,800 Walgreens stores.

----------

Deltex Medical Group PLC, up 5.1% at 1.26p, 12-month range 1.05p-2.34p. The medical devices manufacturer wins contract worth USD200,000 for its TrueVue monitors from an unnamed "key distributor" in the Americas.

----------

AIM - LOSERS

----------

IG Design Group PLC, down 55% at 114.00p, 12-month range 113.00p-625.00p. Shares in craft, gifting and stationery maker hit 12-month low as it says supply chain problems, rising raw material and fulfilment costs, and a drop in demand for crafting in the US have hurt trading. IG Design now expects its financial 2022 adjusted operating profit to fall to a breakeven position, resulting in full year earnings significantly below current market expectations. Says there will be no final dividend payment in relation to the current year and expects that external challenges will continue into financial 2023.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 Nov 2020 09:27

Sensyne Health app to be used in Covid-19 study

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'CVm-Health+' app is to be used by the University of Oxford in its 'FACTS' clinical study evaluating the feasibility and acceptability of new point-of-care tests for regular asymptomatic Covid-19 testing in the community.

Read more
28 Oct 2020 15:33

Sensyne Health Partners With Microsoft To Develop AI Technology

Sensyne Health Partners With Microsoft To Develop AI Technology

Read more
26 Oct 2020 17:43

IN BRIEF: Sensyne Partners With Milton Keynes University Hospital

IN BRIEF: Sensyne Partners With Milton Keynes University Hospital

Read more
23 Oct 2020 16:37

IN BRIEF: Sensyne Health Partners Up With Bristol Myers Squibb

IN BRIEF: Sensyne Health Partners Up With Bristol Myers Squibb

Read more
23 Oct 2020 16:04

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
23 Oct 2020 11:44

Sensyne Health signs research collaboration deal with Bristol Myers Squibb

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a research collaboration agreement with Bristol Myers Squibb, it announced on Friday.

Read more
1 Oct 2020 17:49

IN BRIEF: Sensyne Signs Data Sharing Deal With NHS Greater Glasgow

IN BRIEF: Sensyne Signs Data Sharing Deal With NHS Greater Glasgow

Read more
30 Sep 2020 21:37

IN BRIEF: Sensyne Health To Provide Software For Covid Treatment Trial

IN BRIEF: Sensyne Health To Provide Software For Covid Treatment Trial

Read more
30 Sep 2020 21:13

UK EARNINGS SUMMARY: Gama Aviation Interim Loss Widens As Revenue Down

UK EARNINGS SUMMARY: Gama Aviation Interim Loss Widens As Revenue Down

Read more
29 Sep 2020 12:45

Acacia Research buys 11.8% stake in Sensyne Health

(Sharecast News) - US-based Acacia Research has acquired LF Equity Income Fund's 11.8% stake in AIM-listed artificial intelligence specialist Sensyne Health.

Read more
10 Sep 2020 19:21

IN BRIEF: Sensyne Health Names Macdonnell As New Operating Chief

IN BRIEF: Sensyne Health Names Macdonnell As New Operating Chief

Read more
10 Sep 2020 10:09

Sensyne Health signs up Michael Macdonnell as new COO

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has appointed Michael Macdonnell to its senior management team, it announced on Thursday, as its chief operating officer.

Read more
3 Sep 2020 21:22

IN BRIEF: Sensyne Health Launches Sense Engine In UK

IN BRIEF: Sensyne Health Launches Sense Engine In UK

Read more
19 Aug 2020 10:16

Sensyne Health Develops New Diabetes Software Application DBm-Health

Sensyne Health Develops New Diabetes Software Application DBm-Health

Read more
10 Aug 2020 10:45

IN BRIEF: Sensyne Settles Tribunal Claim With Former Finance Chief

IN BRIEF: Sensyne Settles Tribunal Claim With Former Finance Chief

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.